Articles |
From the Institute of Interdisciplinary Research, School of Medicine, Université Libre de Bruxelles (Belgium).
Correspondence to Dr D. Communi, Institute of Interdisciplinary Research, Université Libre de Bruxelles, Campus Erasme, Building C, 808 Route de Lennik, 1070 Brussels, Belgium.
| Abstract |
|---|
|
|
|---|
Key Words: ATP P2 receptors endothelial cells inositol phosphates choline
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
(120 Ci/mmol)
were from Amersham. Dowex AG1X8 (formate form) was from Bio-Rad
Laboratories. Pluronic F-127 and fura 2-AM were from Molecular Probes.
The µBondapack C18 column (3.9x300 mm) was purchased from Waters
Millipore. The solvents for high-performance liquid chromatography
(HPLC) were obtained from Romil Chemicals Limited.
Cell Culture
BAECs were obtained by collagenase digestion of the aorta
excised from a freshly slaughtered cow and cultured in a medium
composed of minimum essential medium (MEM) D-valine (90%
[vol/vol]), fetal calf serum (10% [vol/vol]), 2 mmol/L glutamine,
100 U penicillin per milliliter, 100 µg streptomycin per milliliter,
and 2.5 µg amphotericin B per milliliter. MEM D-valine
was used to prevent survival of contaminating smooth muscle cells. The
cells were incubated at 37°C in a humidified airCO2
(19:1) incubator. When the primary culture formed a confluent
monolayer, the cells were harvested with trypsin (0.1% [wt/vol]) in
a Ca2+- and Mg2+-free Hanks'
buffer and subcultured in 35-mm-diameter Petri dishes. For the second
and the following passages, the medium was replaced by Dulbecco's
modified Eagle's medium (DMEM, 70% [vol/vol]), Ham's F-12 medium
(20% [vol/vol]), fetal calf serum (10% [vol/vol]), antibiotics,
amphotericin B, and glutamine at the same concentrations. The cells
were used between the second and fourth passages.
Measurement of Cytosolic Calcium in Single Cells
[Ca2+]i was measured in BAECs
by using the fluorescent Ca2+ indicator fura 2 as
described initially by Grynkiewicz et al.14 Practically,
the cells were cultured on circular glass coverslips, in the same
culture medium as described above (except with the omission of
amphotericin B). The cells were seeded either at low or high density to
measure the [Ca2+]i on individual
cells or on a cell population. After 1 day of culture, the cells were
incubated at room temperature in the dark for 30 minutes in a HEPES
buffer (mmol/L: NaCl 120, KCl 5, MgCl2 1, CaCl2
1, glucose 10, and HEPES 20, pH 7.4) supplemented with pluronic F-127
(0.025%, 1/1000 dilution from a stock in dimethyl sulfoxide) and with
fura 2-AM (1 µmol/L). After loading, the cells were quickly washed
with the HEPES buffer and allowed to equilibrate at room temperature
for 15 to 30 minutes in the dark in the same HEPES buffer. Then the
coverslips were mounted in a homebuilt device placed on the stage of a
Nikon Diaphot inverted microscope coupled to a Spex CM-1 fluorometer
and incubated at room temperature in the HEPES buffer described above.
The total volume of the device chamber was 250 µL. Fresh medium could
be either perfused from the bottom of the chamber or added from its
top. Excess medium was retrieved by a peristaltic pump through a tube
placed in such a way that the remaining volume was kept constantly at
100 µL. The cells were challenged by adding 100 µL of a twofold
concentrated solution from the top of the chamber. The cells were
observed through a Nikon x100 oil immersion (numerical aperture, 1, 3)
objective. Individual cells (with no contact with other cells as
assessed by transmission microscopy) were isolated through a diaphragm
for fluorescence measurements. They were excited alternatively at 340
and 380 nm through a Nikon DM400 dichroic mirror by using the
excitation source of the Spex CM-1 fluorometer. The emission light was
collected through a Nikon BA520 barrier filter with a photomultiplier
tube connected to the Spex CM-1 fluorometer. The ratio between the
fluorescence intensities recorded after excitation at 340 and 380 nm is
related to the [Ca2+]i.14
The BAEC [Ca2+]i values were
calculated accordingly from those fluorescence ratio values; after that
the ratios of minimal and maximal fluorescence were obtained; at the
end of the experiment, the experimental buffer was replaced by an EGTA
buffer (mmol/L: NaCl 120, KCl 5, MgCl2 1, HEPES 20, and
EGTA 50, pH 7.4), and the Ca2+-free fluorescence
values were obtained after the addition of 25 µmol/L 4-BrA23187. The
Ca2+-saturated fluorescence values were obtained
after washing of the EGTA buffer and after exposure of the cells to a
high-Ca2+ buffer (mmol/L: choline chloride 120, KCl
5, MgCl2 1, CaCl2 50, caffeine 10, and HEPES
20, pH 7.4).
Measurement of PGI2 Release
Endothelial cells were isolated from bovine aorta as described
above, seeded in 16-mm-diameter wells of 24-well plastic trays, and
incubated for 5 hours in complete medium supplemented or not with
cycloheximide (2 µg/mL). Cells were then washed with DMEM and
equilibrated in this medium for 20 minutes. The agonists (ATP, UTP, and
2MeSATP) or water were added for an additional 20 minutes. The
production of PGI2 was measured by the radioimmunoassay of
its stable degradation product 6-ketoprostaglandin F1
directly in the incubation medium as described
previously.15
Measurement of InsPs
Cell Labeling and InsP Extraction
Subconfluent cells were incubated for 24 hours in a medium
containing inositol-free MEM, fetal calf serum (5% [vol/vol]),
antibiotics, and amphotericin B as described above, supplemented with
D-myo-[3H]inositol (10 µCi/mL). Cells
were then washed twice with DMEM and incubated in this medium for 30
minutes before the addition of the agonist; the incubation was stopped
after 15 seconds by rapidly replacing the medium with 1 mL
HClO4 (3% [vol/vol]). The dishes were rinsed with 1 mL
HClO4 (1% [vol/vol]), and the lysates were neutralized
with KOH (0.765 mol/L) and HEPES (0.375 mol/L) to a final pH of 8.
After 30 minutes at 0°C, KClO4 was eliminated by
centrifugation (1500g for 10 minutes at 4°C). The
supernatant was collected, and the pellet was washed with 1 mL of a
mixture of Na2B4O7 (5 mmol/L) and
EDTA (0.5 mmol/L) and recentrifuged as before. Five milliliters of this
mixture (5 mmol/L Na2B4O7 and 0.5
mmol/L EDTA) was added to the pool of the two supernatants.
InsP Separation
This separation was achieved by chromatography on Dowex AG1X8
(formate form). Inositol, glycerophosphoinositol,
InsP1, InsP2, and
InsP3 were eluted sequentially with 20 mL of water, 8 mL of
60 mmol/L ammonium formate/5 mmol/L
Na2B4O7, 20 mL of 150 mmol/L
ammonium formate/5 mmol/L
Na2B4O7, 18 mL of 0.4 mol/L
ammonium formate/0.1 mol/L formic acid, and 12 mL of 0.7 mol/L ammonium
formate/0.1 mol/L formic acid, respectively. A 4-mL aliquot of each
fraction was counted by liquid scintillation.
Separation of InsP3 and InsP4 Isomers by
HPLC
The cells were incubated for 48 hours in a medium containing
inositol-free MEM, fetal calf serum (5% [vol/vol]), antibiotics, and
amphotericin B as described above, supplemented with
D-myo-[3H]inositol (10 µCi/mL). Cells
were then washed twice with inositol-free MEM and incubated in this
medium for 30 minutes, agonists were added for 15 seconds, and
reactions were stopped by replacing the medium with 0.5 mL of 20%
trichloroacetic acid (TCA) [vol/vol], 10 mmol/L EDTA, and 0.2 mg/mL
phytic acid hydrolysate.16 The cells were scraped, and the
dishes were rinsed with an equal volume of water. The proteins were
eliminated by centrifugation, and the TCA contained in the supernatant
was removed after five extractions with 3 mL diethyl ether. The samples
were adjusted to pH 4 with 0.1 mol/L KOH and concentrated by using a
Speed-Vac. They were resuspended in 400 µL of 50 mmol/L
tributylammonium (pH 4). InsP3 and InsP4
isomers were separated on a µBondapack C18 column eluted
isocratically in 5 mmol/L tributylammonium, 10% methanol, and 100
mmol/L KH2PO4 (pH 4) at a 1.2-mL/min flow rate.
Fractions of 0.10 and 0.25 minutes were collected for InsP3
and InsP4, respectively. The samples were coinjected
with
300 cpm [32P]Ins(1,3,4,5)P4.
[32P]Ins(1,3,4,5)P4 was prepared from
Ins(1,4,5)P3 and [
-32P]ATP with a purified
Ins(1,3,4)P3 3 kinase.
Assay of Choline Release
BAECs were labeled during a 24-hour incubation in 1 mL of
complete culture medium containing 10 µCi
[methyl-3H]choline (80 µCi/mmol). The cells
were then washed twice with DMEM and incubated in 1 mL of DMEM in the
presence of the tested agents. Aliquots of the incubation media (100
µL) were collected at various times for liquid scintillation
counting.
Protein Phosphorylation
After labeling with [32P]phosphate, the
phosphorylated proteins from BAECs were resolved by two-dimensional gel
electrophoresis, as previously described.17
| Results |
|---|
|
|
|---|
|
Prostacyclin Release From Freshly Isolated BAECs
UTP stimulates the release of PGI2 from porcine aortic
endothelial cells4 but does not induce
endothelium-dependent relaxation in the porcine
aorta.18 One possible explanation of this discrepancy
would be that the P2U receptors are not present on the
aortic endothelium in situ but are induced in cell culture. To test
this hypothesis, we measured the release of PGI2 from ATP-
and UTP-stimulated BAECs shortly after their isolation, as described in
"Materials and Methods." Fig 2
shows that both UTP
and ATP stimulated the release of PGI2 from these freshly
isolated cells. To exclude the possibility that the response to UTP
could be mediated by receptors rapidly neosynthesized as a consequence
of the cell isolation procedure, cycloheximide was included in the
incubation fluid during the 5-hour period between collagenase digestion
and testing (Fig 2
) or even in the collagenase-containing harvesting
medium (data not shown). The UTP response was maintained in the
presence of cycloheximide at a concentration (2 µg/mL=7 µmol/L)
known to produce a 95% inhibition of protein synthesis in
BAECs.15 The stimulation induced by UTP was 6.9-fold in
the absence of cycloheximide and 5.3-fold in its presence (mean of
three independent experiments).
|
InsP Accumulation in BAECs Stimulated by ATP, UTP, and 2MeSATP
As shown in Fig 3
, the time courses of the
accumulation of InsP3 in response to ATP, UTP, and 2MeSATP
were fundamentally similar with a rapid and transient action; a maximum
stimulation was reached after 10 to 15 seconds of incubation in the
presence of the agonist, and the level had almost returned to the
baseline after 1 minute (Fig 3
). This rapid time course had been
observed previously in ATP-stimulated BAECs.5 19 If we
consider the stimulations at 15 seconds, the responses to 2MeSATP (20
µmol/L) and to UTP (100 µmol/L) represented 63±17%
and 94±23%, respectively, of the response to ATP (100 µmol/L)
(mean±SD of four independent experiments).
|
InsP3 and InsP4 Isomer Characterization by
Ion-Pairing Reverse-Phase HPLC
The time courses of production of Ins(1,4,5)P3,
Ins(1,3,4,5)P4, and Ins(1,3,4)P3 were
comparable in UTP and in 2MeSATP-stimulated cells (Fig 4
) and were also similar to that previously reported for
the effect of ATP20 : (1) The accumulation of
Ins(1,4,5)P3 was abundant, rapid in onset (maximum in 15 to
30 seconds), and transient (return to baseline in 1 minute). (2)
Ins(1,3,4,5)P4 also rapidly increased after the addition of
the agonist (maximum level was obtained within the minute) but to a
lesser extent than Ins(1,4,5)P3, and its level had
only slightly decreased after 10 minutes. (3) Significant increase of
the Ins(1,3,4)P3 level was observed after only 30 seconds
of stimulation, and the maximal production obtained after 1 minute was
maintained for at least 10 minutes. The ratio between the three isomers
was the same after stimulation of the cells with UTP or with 2MeSATP
(Fig 4
).
|
Differential Modulation of the Accumulation of InsP3 by
Protein Kinase C
We investigated the effect of protein kinase C (PKC) activation by
PMA on the production of InsP3 induced by ATP, UTP, and
2MeSATP. The response to 2MeSATP was rapidly and markedly inhibited
after pretreatment of the cells with PMA (50 nmol/L) (Fig 5
): the inhibitions were 74% after a pretreatment of 6
minutes, 92% after 12 minutes, and 100% after 30 minutes (mean of two
independent experiments). The stimulation of InsP3
accumulation by UTP was inhibited by PMA to a lower extent and with a
slower time course (Fig 5
): 16% after 6 minutes, 23% after 12
minutes, and 42% after 30 minutes (mean of two independent
experiments). To exclude the possibility that the greater sensitivity
to PMA of the 2MeSATP response was due to its lower magnitude compared
with the UTP response, we investigated the effect of PMA (50 nmol/L) at
different concentrations of UTP and 2MeSATP, producing stimulations of
overlapping intensities. As shown on Fig 6
, the
inhibition by PMA was stronger for 2MeSATP (70% to 100%) than for UTP
(10% to 30%) at all concentrations tested. In particular, at
concentrations of agonists producing comparable effects on
InsP3, the inhibitions were, respectively, 28±8%
for UTP (10 µmol/L) and 83±9% for 2MeSATP (1 µmol/mL) (mean±SD
of three independent experiments). As shown in Fig 7
, we
observed that the inhibition of the response to ATP after a
pretreatment of 10 minutes of the cells with PMA was intermediately
between that of the UTP and 2MeSATP responses. The inhibitions observed
were 46±19% for 100 µmol/L ATP, 25±22% for 100 µmol/L UTP, and
82±16% for 20 µmol/L 2MeSATP (mean±SD of seven independent
experiments). This is consistent with the involvement of both
P2Y and P2U receptors in the response to ATP.
In contrast with its selective effect on the P2Y-mediated
generation of InsP3, PMA reduced the rise in
[Ca2+]i induced by both 2MeSATP and
UTP (data not shown). This result is not unexpected; in many cell
types, PMA lowers [Ca2+]i
independently from InsP3, at least partially by
stimulating Ca2+ extrusion.21 22 23
|
|
|
Choline Release
In BAECs, ATP stimulates the phospholipase D hydrolysis of
phosphatidylcholine into choline and phosphatidic
acid.24 25 2MeSATP and UTP also stimulated the release of
[3H]choline metabolites from BAECs, and they produced
very similar maximal responses (Fig 8
): the maximal
responses to UTP (100 µmol/L) and 2MeSATP (20 µmol/L)
represented, respectively, 98±5% and 93±13% of the
responses to ATP (100 µmol/L) (mean±SD of five independent
experiments). Considering the importance of PKC in the action of ATP on
the phosphatidylcholine metabolism in BAECs,24 we
investigated the effect of a 24-hour exposure of the cells to PMA (500
nmol/L) on the UTP and 2MeSATP responses. Such a long pretreatment is
known to deplete the cells in PKC.24 As shown on Fig 9
,
top, the release of choline induced by ATP, UTP, and
2MeSATP was completely abolished after prolonged PMA treatment, whereas
the InsP3 accumulation induced by the same agonists was not
affected (Fig 9
, bottom). These data indicate that PKC plays a crucial
role in the activation of phospholipase D by both P2Y and
P2U receptors, at a step distal to phospholipase C
activation.
|
|
Protein Phosphorylation
The phosphorylation of BAEC proteins has been analyzed previously
by Demolle et al,17 who used two-dimensional gel
electrophoresis; their study revealed an increased phosphorylation of
18-, 28-, and 36-kD substrates after a 10-minute stimulation by ATP.
These various substrates were also phosphorylated in response to UTP
and 2MeSATP (see arrows on Fig 10
), and no consistent
difference could be detected between the phosphorylation patterns
induced by the two agonists.
|
| Discussion |
|---|
|
|
|---|
-glutamyltranspeptidasepositive cells have been identified; these
cells were few in number and randomly distributed in the
monolayers.28 Therefore, the hypothesis that
P2Y and P2U receptors might be segregated on
distinct subpopulations of BAECs deserved to be tested. Our
measurements of single-cell [Ca2+]i
have demonstrated that most BAECs respond to both 2MeSATP and UTP,
indicating the colocalization of P2Y and P2U
receptors on the same cells. Nevertheless, the existence of small
subpopulations of cells responsive only to UTP (or 2MeSATP) cannot be
excluded. It is known that UTP stimulates the release of PGI2 from cultured porcine aortic endothelial cells4 but does not induce an endothelium-dependent relaxation of the porcine aorta, unlike 2MeSATP, which behaves as a full agonist.18 Analogous with the observation that muscarinic receptor expression differs between freshly isolated and cultured endothelial cells,29 one possible explanation for this discrepancy could be that P2U receptors are not expressed on endothelial cells in situ in the aorta but appear in culture. This is not the case, since we have now shown that UTP mimics the stimulatory effect of ATP on PGI2 release from BAECs shortly after their isolation by collagenase digestion. Furthermore, inclusion of cycloheximide in the incubation medium, or even in the collagenase-containing collection fluid, did not decrease the response to UTP. These results allow us to exclude the possibility that P2U receptors were rapidly neosynthesized in response to the isolation procedure and indirectly support the view that they are expressed on endothelial cells in situ in the bovine aorta. This conclusion is consistent with the recent report that both P2Y and P2U receptors mediate an endothelium-dependent relaxation of bovine intercostal arteries.30 The lack of P2U-mediated endothelium relaxation in the porcine aorta18 remains thus unexplained.
In the present study, ATP, UTP, and 2MeSATP induced InsP3 accumulation with a similar rapid time course, characteristic of aortic endothelial cells5 19 20 ; the time course is definitely slower in microvascular endothelial cells,5 10 probably as a result of higher 3-kinase activity.5 Our results differ from those of Purkiss et al,31 who reported that the response to UTP was more sustained than that to 2MeSATP. The reason for that discrepancy is unclear; it might be related to a difference in methodology, since these authors used a mass assay of InsP3, whereas we used a radiolabeling procedure. The possibility of a receptor-specific regulation of InsP3-kinase is supported by the observation that in human umbilical vein endothelial cells, histamine induces a larger accumulation of InsP4 than thrombin, although the rate of Ins(1,4,5)P3 formation is similar in response to the two agonists.32 Therefore, we compared the time course and relative magnitude of Ins(1,4,5)P3, Ins(1,3,4)P3, and InsP(1,3,4,5)P4 accumulation in response to UTP versus 2MeSATP but also found no difference. Like ATP, UTP and 2MeSATP stimulated the release of choline from prelabeled cells, presumably as a consequence of phospholipase D activation.24 25 The effects of the three agonists were inhibited to the same extent after a prolonged incubation of the cells with PMA to downregulate protein kinase C, whereas under the same experimental conditions, their effect on InsP3 accumulation was maintained. These results indicate that the activation of phospholipase D mediated by either P2Y or P2U receptors is dependent on PKC at a step distal to phospholipase C activation.
One difference that we have identified between P2Y and
P2U receptor-mediated phospholipase C activation in BAECs
is a differential sensitivity to desensitization by PMA. The effect of
2MeSATP on InsP3 was more strongly and more rapidly
inhibited by PMA than was the UTP effect. The difference between the
two agonists was observed over the entire concentration-action curve
and in particular at concentrations of these agonists that produced a
comparable stimulation of InsP3 formation. The inhibition
of the ATP response was intermediately between the inhibition of the
UTP and 2MeSATP effects. This differential sensitivity to PMA has been
observed also by Purkiss et al31 and is reminiscent of the
differential effect of pertussis toxin on the formation of
InsP3 induced by UTP or 2MeSATP1 : pertussis
toxin inhibited the response to UTP and to ATP in a similar way but had
no effect on the response to 2MeSATP. In this respect, the
P2Y receptor behaves like the thrombin and bradykinin
receptors, whose coupling to phospholipase C in endothelial cells is
insensitive to pertussis toxin but inhibited by PMA.33 34 35 36
It is currently accepted that receptor-mediated phospholipase C
activation can involve distinct G proteins: either a member of the
pertussis toxininsensitive Gq/G11
family or a pertussis toxinsensitive Gi
protein.37 38 The ß1 isoform of
phospholipase C is activated by
q/
11, whereas the ß
dimer of Gi2 stimulates the ß2 isoform of
phospholipase C.38 Taken together, the data on endothelial
cells are consistent with the hypothesis that the P2Y
receptors are coupled to Gq/G11,
whereas the P2U receptors would be coupled to
Gi2.
| Acknowledgments |
|---|
Received January 5, 1994; accepted October 31, 1994.
| References |
|---|
|
|
|---|
2.
Burnstock G, Kennedy C. A dual function for adenosine
5'-triphosphate in the regulation of vascular tone: excitatory
cotransmitter with noradrenaline from perivascular nerves and locally
released inhibitory intravascular agent. Circ Res. 1986;58:319-330.
3. Needham L, Cusack NJ, Pearson JD, Gordon JL. Characteristics of the P2 purinoceptor that mediates prostacyclin production by pig aortic endothelial cells. Eur J Pharmacol. 1987;134:199-209. [Medline] [Order article via Infotrieve]
4.
Motte S, Pirotton S, Boeynaems JM. Heterogeneity of ATP
receptors in aortic endothelial cells: involvement of P2y
and P2u receptors in the inositol phosphate response.
Circ Res. 1993;72:504-510.
5. Allsup DJ, Boarder MR. Comparison of P2-purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and of inositol phosphate response. Mol Pharmacol. 1990;38:84-91. [Abstract]
6. Lustig KD, Erb L, Landis DM, Hicks-Taylor CS, Zhang X, Sportiello MG, Weisman GA. Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells. Biochim Biophys Acta. 1992;1134:61-72. [Medline] [Order article via Infotrieve]
7. Lustig KD, Sportiello MG, Erb L, Weisman GA. A nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionized forms of ATP and UTP. Biochem J. 1992;284:733-739.
8. Kitazono T, Takeshige K, Minakami S. Activation of cultured bovine aortic endothelial cells by extracellular pyrimidine trisphosphate. Int J Biochem. 1992;24:1323-1327. [Medline] [Order article via Infotrieve]
9. Purkiss JR, Wilkinson GF, Boarder MR. Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D. Br J Pharmacol. 1993;108:1031-1037. [Medline] [Order article via Infotrieve]
10. Mannix RJ, Moatter T, Kelley KA, Gerritsen ME. Cellular signalling responses mediated by a novel nucleotide receptor in rabbit microvessel endothelium. Am J Physiol. 1993;265:11675-11680.
11.
Frelin C, Breittmayer JP, Vigne P. ADP induces inositol
phosphate-independent intracellular Ca2+
mobilization in brain capillary endothelial cells. J Biol
Chem. 1993;268:8787-8792.
12. Wilkinson GF, Purkiss JR, Boarder MR. The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2y-purinoceptors and nucleotide receptors linked to phospholipase C. Br J Pharmacol. 1993;108:689-693. [Medline] [Order article via Infotrieve]
13. O'Connor SE, Dainty IA, Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci. 1991;12:137-141. [Medline] [Order article via Infotrieve]
14.
Grynkiewicz G, Poenie M, Tsien RY. A new generation of
Ca2+-indicators with greatly improved fluorescence
properties. J Biol Chem. 1985;260:3440-3450.
15. Boeynaems JM, Boutherin-Falson O, Lagneau C, Galand N. Enhancement of the endothelial production of prostacyclin by inhibitors of protein synthesis. Br J Pharmacol. 1990;101:799-802. [Medline] [Order article via Infotrieve]
16. Wregget KA, Howe LR, Moor JP, Irvine RF. Extraction and recovery of inositol phosphates from tissues. Biochem J. 1987;245:933-934. [Medline] [Order article via Infotrieve]
17.
Demolle D, Lecomte M, Boeynaems JM. Pattern of protein
phosphorylation in aortic endothelial cells. J Biol Chem. 1988;263:18459-18465.
18. Martin W, Cusack NJ, Carleton JS, Gordon JL. Specificity of P2-purinoceptor that mediates endothelium-dependent relaxation of the pig aorta. Eur J Pharmacol. 1985;108:295-299. [Medline] [Order article via Infotrieve]
19.
Pirotton S, Raspe E, Demolle D, Erneux C, Boeynaems JM.
Involvement of inositol(1,4,5)trisphosphate and calcium in the action
of adenine nucleotides on aortic endothelial cells. J Biol
Chem. 1987;262:17461-17466.
20. Pirotton S, Verjans B, Boeynaems JM, Erneux C. Metabolism of inositol phosphates in ADP-stimulated vascular endothelial cells. Biochem J. 1991;277:103-110.
21. Tsien RY, Pozzan T, Rink TJ. T-cell mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes. Nature. 1982;295:68-71. [Medline] [Order article via Infotrieve]
22. Drummond AH. Bidirectional control of cytosolic calcium by thyrotropin-releasing hormone in pituitary cells. Nature. 1985;315:752-755. [Medline] [Order article via Infotrieve]
23.
Rink TJ, Sage SO. Stimulated calcium efflux from fura-2-loaded
human platelets. J Physiol (Lond). 1987;393:513-524.
24. Pirotton S, Robaye B, Lagneau C, Boeynaems JM. Adenine nucleotides modulate phosphatidylcholine metabolism in aortic endothelial cells. J Cell Physiol. 1990;142:449-457. [Medline] [Order article via Infotrieve]
25.
Martin TW, Michaelis K. P2-purinergic agonists
stimulate phosphodiesteratic cleavage of phosphatidylcholine in
endothelial cells: evidence for activation of phospholipase D. J
Biol Chem. 1989;264:8847-8856.
26. Takeda K, Schini V, Stoeckel H. Voltage-activated potassium, but not calcium currents, in cultured bovine aortic endothelial cells. Eur J Physiol. 1987;410:385-393. [Medline] [Order article via Infotrieve]
27. Bossu JL, Elhamdani A, Feltz A, Tanzi F, Aunis D, Thierse D. Voltage-gated Ca2+ entry in isolated bovine capillary endothelial cells: evidence of a new type of BAY K 8644-sensitive channel. Pflugers Arch. 1992;520:200-207.
28.
Wang BL, Grammas P, De Bault L. Characterization of a
-glutamyl transpeptidase positive subpopulation of endothelial cells
in a spontaneous tube-forming clone of rat cerebral resistance-vessel
endothelium. J Cell Physiol. 1993;156:531-540. [Medline]
[Order article via Infotrieve]
29.
Tracey WR, Peach MJ. Differential muscarinic
receptor mRNA expression by freshly isolated and cultured bovine aortic
endothelial cells. Circ Res. 1992;70:234-240.
30. Wilkinson GF, McKechnie K, Dainty IA, Boarder MR. P2y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin. J Pharmacol Exp Ther. 1994;268: 881-887.
31. Purkiss JR, Wilkinson GF, Boarder MR. Differential regulation of inositol 1,4,5-trisphosphate by co-existing P2y-purinoceptors and nucleotide receptors on bovine aortic endothelial cells. Br J Pharmacol. 1994;111:723-728. [Medline] [Order article via Infotrieve]
32. Wreggett KA, Irvine RF. Evidence for receptor-specific regulation of the metabolism of the second messenger, inositol trisphosphate, in human endothelial cells. Biochem Biophys Res Commun. 1993;193:855-863. [Medline] [Order article via Infotrieve]
33. Brock TA, Capasso EA. Thrombin and histamine activate phospholipase C in human endothelial cells via a phorbol ester-sensitive pathway. J Cell Physiol. 1988;136:54-62.[Medline] [Order article via Infotrieve]
34.
Brock TA, Capasso EL. GTP
S increases thrombin-mediated
inositol trisphosphate accumulation in permeabilized human endothelial
cells. Am Rev Respir Dis. 1989;140:1121-1125. [Medline]
[Order article via Infotrieve]
35.
Lambert TL, Kent RS, Whorton AR. Bradykinin stimulation of
inositol polyphosphate production in porcine aortic endothelial cells.
J Biol Chem. 1986;261:15288-15293.
36. Voyno-Yasenetskaya TA, Tkachuk VA, Cheknyova EG, Panchenko MP, Grigorian GY, Vajrek RJ, Steward JM, Ryan US. Guanine nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells. FASEB J. 1989;3:44-51. [Abstract]
37.
Smrcka AV, Helper JR, Brown KO, Sternweis PC.
Regulation of phosphoinositide-specific phospholipase C activity by
purified Gq. Science. 1991;251:804-807.
38.
Birnbaumer L. Receptor-to-effector signalling through G
proteins: roles for ß
dimers as well as
subunits.
Cell. 1992;71:1069-1072.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
I. Bar, P.-J. Guns, J. Metallo, D. Cammarata, F. Wilkin, J.-M. Boeynams, H. Bult, and B. Robaye Knockout Mice Reveal a Role for P2Y6 Receptor in Macrophages, Endothelial Cells, and Vascular Smooth Muscle Cells Mol. Pharmacol., September 1, 2008; 74(3): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hong, D. Jaron, D. G. Buerk, and K. A. Barbee Heterogeneous response of microvascular endothelial cells to shear stress Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2498 - H2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Sylte, C. J. Kuckleburg, T. J. Inzana, P. J. Bertics, and C. J. Czuprynski Stimulation of P2X receptors enhances lipooligosaccharide-mediated apoptosis of endothelial cells J. Leukoc. Biol., June 1, 2005; 77(6): 958 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Olearczyk, A. H. Stephenson, A. J. Lonigro, and R. S. Sprague Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H940 - H945. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Ramirez and D. L. Kunze P2X purinergic receptor channel expression and function in bovine aortic endothelium Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2106 - H2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vassort Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium Physiol Rev, April 1, 2001; 81(2): 767 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bouchie, H.-C. Chen, R. Carney, J. C. Bagot, P. A. Wilden, and E. P. Feener P2Y Receptor Regulation of PAI-1 Expression in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 866 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Dubyak Focus on "Multiple functional P2X and P2Y receptors in the luminal and basolateral membranes of pancreatic duct cells" Am J Physiol Cell Physiol, August 1, 1999; 277(2): C202 - C204. [Full Text] [PDF] |
||||
![]() |
T. Noll, H. Holschermann, K. Koprek, D. Gunduz, W. Haberbosch, H. Tillmanns, and H. M. Piper ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+]i Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1892 - H1901. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Arellano, E. Garay, and R. Miledi Cl- currents activated via purinergic receptors in Xenopus follicles Am J Physiol Cell Physiol, February 1, 1998; 274(2): C333 - C340. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Communi, C. Govaerts, M. Parmentier, and J.-M. Boeynaems Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase J. Biol. Chem., December 19, 1997; 272(51): 31969 - 31973. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Seye, A.-P. Gadeau, D. Daret, F. Dupuch, P. Alzieu, L. Capron, and C. Desgranges Overexpression of the P2Y2 Purinoceptor in Intimal Lesions of the Rat Aorta Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3602 - 3610. [Abstract] [Full Text] |
||||
![]() |
D. Communi, N. S. Gonzalez, M. Detheux, S. Brezillon, V. Lannoy, M. Parmentier, and J.-M. Boeynaems Identification of a Novel Human ADP Receptor Coupled to Gi J. Biol. Chem., October 26, 2001; 276(44): 41479 - 41485. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Ramirez and D. L. Kunze P2X purinergic receptor channel expression and function in bovine aortic endothelium Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2106 - H2116. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |